References
- Marsh RA, Vaughn G, Kim MO, . Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. Blood 2010;116:5824–5831.
- Sato E, Ohga S, Kuroda H, . Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan. Am J Hematol 2008;83:721–727.
- Murashige N, Kami M, Kishi Y, . Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms. Br J Haematol 2005;130:561–567.
- Gaulard P, Swerdlow SH, Harris NL, . Other iatrogenic immunodeficiency-associated lymphoproliferative disorder In: Swerdlow SH, Campo E, Harris NL, ., editors. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. pp 350–351.
- Ishii E, Ohga S, Imashuku S, . Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 2007;86:58–65.
- Daikeler T, Hügle T, Farge D, .; Working Party Autoimmune Diseases of the EBMT. Allogeneic hematopoietic SCT for patients with autoimmune diseases. Bone Marrow Transplant 2009;44:27–33.
- Hügle T, Daikeler T. Stem cell transplantation for autoimmune diseases. Haematologica 2010;95:185–188.
- Henter JI, Horne A, Aricó M, . HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124–131.